CORD-19:038354e8830fe01feb621a12e8a8c467a15b6354 / 114318-114507 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T695","span":{"begin":0,"end":189},"obj":"Sentence"},{"id":"T55986","span":{"begin":0,"end":189},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The two major concerns on the part of the FDA after their initial advisory panel review in 2001 related to the questions of increased risk of pneumonia and asthma in vaccinated individuals."}

{"project":"Epistemic_Statements","denotations":[{"id":"T280","span":{"begin":0,"end":189},"obj":"Epistemic_statement"}],"text":"The two major concerns on the part of the FDA after their initial advisory panel review in 2001 related to the questions of increased risk of pneumonia and asthma in vaccinated individuals."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T100","span":{"begin":0,"end":189},"obj":"Sentence"}],"text":"The two major concerns on the part of the FDA after their initial advisory panel review in 2001 related to the questions of increased risk of pneumonia and asthma in vaccinated individuals."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T640","span":{"begin":142,"end":151},"obj":"Disease"},{"id":"T641","span":{"begin":156,"end":162},"obj":"Disease"}],"attributes":[{"id":"A640","pred":"mondo_id","subj":"T640","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A641","pred":"mondo_id","subj":"T641","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"}],"text":"The two major concerns on the part of the FDA after their initial advisory panel review in 2001 related to the questions of increased risk of pneumonia and asthma in vaccinated individuals."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T164","span":{"begin":142,"end":151},"obj":"Phenotype"},{"id":"T165","span":{"begin":156,"end":162},"obj":"Phenotype"}],"attributes":[{"id":"A164","pred":"hp_id","subj":"T164","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A165","pred":"hp_id","subj":"T165","obj":"http://purl.obolibrary.org/obo/HP_0002099"}],"text":"The two major concerns on the part of the FDA after their initial advisory panel review in 2001 related to the questions of increased risk of pneumonia and asthma in vaccinated individuals."}